MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.900
0.000
0.00%
Closed 16:00 10/18 EDT
OPEN
--
PREV CLOSE
1.900
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.705
52 WEEK LOW
1.628
MARKET CAP
21.05M
P/E (TTM)
-5.8333
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PRPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

PRPH News

  • How Should Investors Feel About ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO Pay?
  • Simply Wall St..09/11 19:23
  • Stocks That Hit 52-Week Lows On Tuesday
  • Benzinga.08/20 14:55
  • ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2019
  • GlobeNewswire.08/12 13:00
  • ProPhase Labs Q2 EPS $(0.11) Down From $(0.02) YoY, Sales $1.65M Down From $3.186M YoY
  • Benzinga.08/12 12:03

More

Industry

Food Processing
-0.36%
Food & Tobacco
-0.26%

Hot Stocks

Name
Price
%Change

About PRPH

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
More

Webull offers ProPhase Labs Inc (PRPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.